Smiths Group Services Corporation

Based in DC

🤖

AI Overview

With $9.2M in lobbying spend across 33 quarterly filings, Smiths Group Services Corporation is one of the biggest lobbying spenders in Washington. Their lobbying covers 13 issue areas. Active from 2018 to 2025.

$9.2M
Total Spend
8
Years Active
1
Firms Hired
4
Lobbyists Deployed
13
Issues Lobbied

Spending Trend

View as table
YearLobbying Spend
2018$1.7M
2019$2.0M
2020$1.1M
2021$990K
2022$1.0M
2023$790K
2024$1.0M
2025$560K

Issues Lobbied

Lobbying Firms

Lobbyists

Government Agencies Targeted

These are the government entities that Smiths Group Services Corporation disclosed contacting in their lobbying filings.

Army, Dept of (Other)Centers For Medicare and Medicaid Services (CMS)Defense, Dept of (DOD)Energy, Dept ofEnvironmental Protection Agency (EPA)Executive Office of the President (EOP)Health & Human Services, Dept of (HHS)Homeland Security, Dept of (DHS)HOUSE OF REPRESENTATIVESJustice, Dept of (DOJ)Office of Policy DevelopmentSENATETransportation Security Administration (TSA)U.S. Customs & Border ProtectionU.S. Trade Representative (USTR)Navy, Dept ofBureau of ReclamationWhite House OfficeFood & Drug Administration (FDA)Nuclear Regulatory Commission (NRC)+3 more
View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Health Issues, Defense, Aviation, Trade, Taxation and 8 more

Reimbursement and policy issues related to non-opioid acute pain management.

FY19 National Defense Authorization; FY18 Department of Defense Appropriations Act (H.R.3219); FY19 Defense Appropriations;

Issues related to CBRNE (Chemical, Biological, Radiological, Nuclear and Exp

H.R.2825, Department of Homeland Security Authorization Act;

Aviation security solutions and detection technologies for the Transportation Security Administration (TSA).

Issues related to the North American Free Trade Agreement (NAFTA).

H.R.184, Protect Medical Innovation Act of 2017; S.108, Medical Device Access and Innovation Protection Act; H.R.4617, To amend the Internal Revenue Code of 1986 to provide for a temporary moratorium

Related Analysis

Related Investigations

Similar Clients

Explore More

Data Sources: Senate LDA Filings

Last updated: February 2026

This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.